Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

222 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Vaccine effectiveness against SARS-CoV-2 transmission and infections among household and other close contacts of confirmed cases, the Netherlands, February to May 2021.
de Gier B, Andeweg S, Joosten R, Ter Schegget R, Smorenburg N, van de Kassteele J; RIVM COVID-19 surveillance and epidemiology team 1,; Hahné SJ, van den Hof S, de Melker HE, Knol MJ; Members of the RIVM COVID-19 surveillance and epidemiology team. de Gier B, et al. Among authors: knol mj. Euro Surveill. 2021 Aug;26(31):2100640. doi: 10.2807/1560-7917.ES.2021.26.31.2100640. Euro Surveill. 2021. PMID: 34355689 Free PMC article.
Vaccine effectiveness against SARS-CoV-2 transmission to household contacts during dominance of Delta variant (B.1.617.2), the Netherlands, August to September 2021.
de Gier B, Andeweg S, Backer JA; RIVM COVID-19 surveillance and epidemiology team; Hahné SJ, van den Hof S, de Melker HE, Knol MJ; RIVM COVID-19 surveillance and epidemiology team (in addition to the named authors). de Gier B, et al. Among authors: knol mj. Euro Surveill. 2021 Nov;26(44):2100977. doi: 10.2807/1560-7917.ES.2021.26.44.2100977. Euro Surveill. 2021. PMID: 34738514 Free PMC article.
Transmissibility of SARS-CoV-2 among fully vaccinated individuals.
Knol MJ, Backer JA, de Melker HE, van den Hof S, Gier B. Knol MJ, et al. Lancet Infect Dis. 2022 Jan;22(1):16-17. doi: 10.1016/S1473-3099(21)00763-5. Lancet Infect Dis. 2022. PMID: 34953541 Free PMC article. No abstract available.
Effectiveness of complete primary vaccination against COVID-19 at primary care and community level during predominant Delta circulation in Europe: multicentre analysis, I-MOVE-COVID-19 and ECDC networks, July to August 2021.
Kissling E, Hooiveld M, Martínez-Baz I, Mazagatos C, William N, Vilcu AM, Kooijman MN, Ilić M, Domegan L, Machado A, de Lusignan S, Lazar M, Meijer A, Brytting M, Casado I, Larrauri A, Murray JK, Behillil S, de Gier B, Mlinarić I, O'Donnell J, Rodrigues AP, Tsang R, Timnea O, de Lange M, Riess M, Castilla J, Pozo F, Hamilton M, Falchi A, Knol MJ, Kurečić Filipović S, Dunford L, Guiomar R, Cogdale J, Cherciu C, Jansen T, Enkirch T, Basile L, Connell J, Gomez V, Sandonis Martín V, Bacci S, Rose AM, Pastore Celentano L, Valenciano M; I-MOVE-COVID-19 and ECDC primary care study teams; I-MOVE-COVID-19 and ECDC primary care study team (in addition to authors above). Kissling E, et al. Among authors: knol mj. Euro Surveill. 2022 May;27(21):2101104. doi: 10.2807/1560-7917.ES.2022.27.21.2101104. Euro Surveill. 2022. PMID: 35620997 Free PMC article.
Elevated risk of infection with SARS-CoV-2 Beta, Gamma, and Delta variants compared with Alpha variant in vaccinated individuals.
Andeweg SP, Vennema H, Veldhuijzen I, Smorenburg N, Schmitz D, Zwagemaker F, van Gageldonk-Lafeber AB, Hahné SJM, Reusken C, Knol MJ, Eggink D; SeqNeth Molecular surveillance group‡ and; RIVM COVID-19 Molecular epidemiology group‡. Andeweg SP, et al. Among authors: knol mj. Sci Transl Med. 2023 Feb 22;15(684):eabn4338. doi: 10.1126/scitranslmed.abn4338. Epub 2023 Feb 22. Sci Transl Med. 2023. PMID: 35862508 Free PMC article.
COVID-19 vaccine effectiveness against SARS-CoV-2 infection during the Delta period, a nationwide study adjusting for chance of exposure, the Netherlands, July to December 2021.
van Ewijk CE, Kooijman MN, Fanoy E, Raven SF, Middeldorp M, Shah A, de Gier B, de Melker HE, Hahné SJ, Knol MJ. van Ewijk CE, et al. Among authors: knol mj. Euro Surveill. 2022 Nov;27(45):2200217. doi: 10.2807/1560-7917.ES.2022.27.45.2200217. Euro Surveill. 2022. PMID: 36367011 Free PMC article.
Higher risk of SARS-CoV-2 Omicron BA.4/5 infection than of BA.2 infection after previous BA.1 infection, the Netherlands, 2 May to 24 July 2022.
Andeweg SP, de Gier B, Vennema H, van Walle I, van Maarseveen N, Kusters NE, de Melker HE, Hahné SJ, van den Hof S, Eggink D, Knol MJ. Andeweg SP, et al. Among authors: knol mj. Euro Surveill. 2023 Feb;28(7):2200724. doi: 10.2807/1560-7917.ES.2023.28.7.2200724. Euro Surveill. 2023. PMID: 36795499 Free PMC article.
222 results